EverSource Wealth Advisors LLC Boosts Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

EverSource Wealth Advisors LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 30.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,094 shares of the company’s stock after acquiring an additional 484 shares during the period. EverSource Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $164,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Harbour Investments Inc. increased its holdings in shares of GE HealthCare Technologies by 4.3% in the third quarter. Harbour Investments Inc. now owns 3,164 shares of the company’s stock valued at $297,000 after purchasing an additional 131 shares during the last quarter. OneDigital Investment Advisors LLC grew its holdings in GE HealthCare Technologies by 7.5% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock valued at $1,295,000 after buying an additional 961 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of GE HealthCare Technologies by 30.7% during the 3rd quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock worth $2,203,000 after acquiring an additional 5,512 shares during the period. Natixis Advisors LLC boosted its position in shares of GE HealthCare Technologies by 36.7% during the 3rd quarter. Natixis Advisors LLC now owns 380,071 shares of the company’s stock valued at $35,670,000 after acquiring an additional 102,000 shares during the last quarter. Finally, Mutual of America Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 5.0% during the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock valued at $5,288,000 after acquiring an additional 2,696 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $82.47 on Tuesday. The company has a market cap of $37.71 billion, a P/E ratio of 19.05, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm’s 50 day moving average price is $87.27 and its 200 day moving average price is $86.12.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

GEHC has been the topic of a number of analyst reports. Wells Fargo & Company lifted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.